Web3 Travel Ecosystem Platform Coinsidings Launches Fifth Round of CSS Token Sale
The Web3 tourism ecosystem platform Coinsidings has announced the official launch of the fifth round of CSS option token subscription, with a participation threshold of locking 50,000 AIA tokens.
It is reported that CSS, as the core equity certificate of the platform, not only allows participation in mainnet token minting and tourism consumption exchange, but also provides future dividend and governance rights. The release ratio for this round remains 10% immediate release + 90% linear unlocking over 10 months, significantly shortening the unlocking period from the originally planned 18 months, thus improving liquidity.
According to Coinsidings officials, CSS will subsequently bind more high-quality RWA projects and gradually open diversified application scenarios such as DeFi staking, DAO voting, and ecosystem dividends, assisting early shareholders in co-building a decentralized global travel ecosystem and sharing the on-chain asset appreciation dividends.
Subscription period: 2025.5.14 14:00 — 2025.5.17 14:00 (UTC+8)
Participation rules: Lock 50,000 AIA
Release plan: 10% released after the end, with 10% released every 30 days, fully unlocked linearly within 10 months.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Analyst Gu Jingci: Follow the trend and adapt flexibly
XRP Ledger adds account control feature, enabling enterprises to manage assets offline.
BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals
October 9 – Goldman Sachs pointed out that India's implementation of a 30% profit margin cap on non-scheduled anticancer drugs (link) will have limited impact on hospitals. The report states that, based on preliminary discussions with hospital chain groups, such drugs account for less than 5% of hospital revenue and 2% to 2.5% of operating profit. The report adds that hospitals can offset the losses by slightly adjusting service charges, such as administration fees. According to a government notice, an expert committee will finalize the list of drugs to be brought under regulation. Driven by the anticipated price cap, the share prices of Max Healthcare MAXE.NS, Apollo Hospitals APLH.NS, and Fortis Healthcare FOHE.NS rose by 1.6% to 2.5%. Previously, since September 30, these stocks had collectively declined by 11% to 11.5%. Year-to-date, FOHE and MAXE are down 11.7% and 14.8%, respectively, while APLH has risen by 11%. (To assist non-English speakers, Reuters provides automated translations of its reports into several other languages. Due to potential errors or missing context in automated translations, Reuters does not guarantee the accuracy of automatic translation texts and offers them solely for readers’ convenience. Reuters accepts no responsibility for any damage or loss caused by using these automated translation features.)
Adding insult to injury! Japanese electronics giant Nidec downgraded by UBS, stock price plunges over 9% and approaches an 11-month low
UBS has downgraded Nidec's rating from "Buy" to "Neutral" and lowered its target price from 2,800 yen to 2,400 yen, citing a more challenging market environment.
Crypto prices
More
